Palisade Bio (PALI) Change in Acquisitions & Divestments (2014 - 2018)
Palisade Bio (PALI) posted quarterly Change in Acquisitions & Divestments of $5.0 million for Q1 2018, down 33.49% quarter-over-quarter from $7.5 million in Q1 2016.
Analysis
Palisade Bio (PALI) Change in Acquisitions & Divestments (2014 - 2018) Analysis & Trends
Palisade Bio (PALI) has reported Change in Acquisitions & Divestments for 4 consecutive years, with $5.0 million the latest figure, recorded in Q1 2018.
- In Q1 2018, Change in Acquisitions & Divestments changed N/A year-over-year to $5.0 million; the TTM figure through Dec 2018 stood at $5.0 million (changed N/A YoY), while the FY2018 annual figure was $5.0 million, changed 0.0% from the prior year.
- Change in Acquisitions & Divestments retreated to $5.0 million in Q1 2018 per PALI's latest filing, from $7.5 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $15.0 million in Q1 2015 and bottomed at $5.0 million in Q1 2018.
- Historically, Change in Acquisitions & Divestments has averaged $9.4 million across 4 years, with a median of $8.8 million in 2014.
- On a YoY basis, Change in Acquisitions & Divestments climbed as much as 49.91% in 2016 and fell as far as 49.91% in 2016.
- Palisade Bio's Change in Acquisitions & Divestments stood at $10.0 million in 2014, then jumped by 50.07% to $15.0 million in 2015, then sank by 49.91% to $7.5 million in 2016, then plunged by 33.49% to $5.0 million in 2018.
- Business Quant data shows PALI's Change in Acquisitions & Divestments at $5.0 million in Q1 2018, $7.5 million in Q1 2016, and $15.0 million in Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2018 | 5.00 Mn |
| Mar 31, 2016 | 7.52 Mn |
| Mar 31, 2015 | 15.01 Mn |
| Sep 30, 2014 | 10.00 Mn |